메뉴 건너뛰기




Volumn 2, Issue 3, 2006, Pages 315-327

Development of hypoxia selective cytotoxins for cancer treatment: An update

Author keywords

[No Author keywords available]

Indexed keywords

1,2 BENZISOXAZOLYL DERIVATIVE; 1,2,4 BENZOTRIAZINE DERIVATIVE; 1,2,4 TRIAZINE DERIVATIVE; 1,2,4 TRIAZINE DI N OXIDE DERIVATIVE; 1,2,4 TRIAZINE N OXIDE DERIVATIVE; 1,4 BIS[[2 (DIMETHYLAMINO N OXIDE)ETHYL]AMINO] 5,8 DIHYDROXYANTHRAQUINONE; 2 ALKYLCARBONYLQUINOXALINE 1,4 DIOXIDE DERIVATIVE; 2 BENZOYL 3 TRIFLUOROMETHYLQUINOXALINE 1,4 DIOXIDE DERIVATIVE; ANTINEOPLASTIC AGENT; AZIDE; CISPLATIN; CYTOTOXIC AGENT; FURAZAN DERIVATIVE; ISOXAZOLE DERIVATIVE; METAL ION; MITOMYCIN C; NITRO DERIVATIVE; NITROFURAN DERIVATIVE; NITROIMIDAZOLE DERIVATIVE; NLCQ 1; PHENAZINE 5,10 DIOXIDE DERIVATIVE; PHENAZINE DERIVATIVE; PRODRUG; QUINONE DERIVATIVE; QUINOXALINE 1,4 DIOXIDE DERIVATIVE; QUINOXALINE DERIVATIVE; RADIOSENSITIZING AGENT; SULFOXIDE; TIRAPAZAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 33746152373     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340606776930808     Document Type: Review
Times cited : (19)

References (113)
  • 14
    • 0035352723 scopus 로고    scopus 로고
    • Recent Advances in Bioreductive Drug Targeting
    • Naylor, M.A.; Thomson, P. Recent Advances in Bioreductive Drug Targeting. Mini Rev. Med. Chem., 2001, 1, 17.
    • (2001) Mini Rev. Med. Chem. , vol.1 , pp. 17
    • Naylor, M.A.1    Thomson, P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.